EDGAR Filing Documents for 0001104659-14-082412

Form 8-K - Current report:

SEC Accession No. 0001104659-14-082412

Filing Date

2014-11-20

Accepted

2014-11-20 16:47:27

Documents

Period of Report

2014-11-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a14-24836_18k.htm	8-K	32134
2	EX-10.1	a14-24836_1ex10d1.htm	EX-10.1	269682
3	EX-10.2	a14-24836_1ex10d2.htm	EX-10.2	20582
4	EX-10.3	a14-24836_1ex10d3.htm	EX-10.3	84728
5	EX-99.1	a14-24836_1ex99d1.htm	EX-99.1	11960
6	GRAPHIC	g248361mmi001.jpg	GRAPHIC	3656
	Complete submission text file	0001104659-14-082412.txt		425779

Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709

Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780

NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)